We'll Face Alzheimer's Together

By Mosikito

"We'll Face Alzheimer's Together" is an informative guide for anyone facing Alzheimer's disease, whether it be a patient, family member, or caregiver. This book is a reflection on the journey through Alzheimer's, offering practical advice, support, and hope for those who are affected by the disease.

The book provides an overview of Alzheimer's disease, its symptoms, and stages. The author also explores the medical and scientific aspects of Alzheimer's, including the latest research findings and treatments available. The author emphasizes the importance of early diagnosis and highlights some of the signs and symptoms to look out for.

• Language: English
• Publisher: Mosikito
• Release date: Apr 19, 2023
• ISBN: 9798223664093

Book preview

What is Alzheimer’s disease?

Alzheimer's disease is a progressive and irreversible neurological disorder that affects the brain, causing a decline in cognitive and functional abilities over time. It is the most common cause of dementia, a syndrome that involves a significant loss of cognitive and intellectual functioning that interferes with daily activities.

Alzheimer's disease is characterized by the accumulation of protein plaques and tangles in the brain, which disrupts the normal functioning of neurons and causes them to die. This, in turn, leads to a loss of brain tissue and an overall shrinking of the brain.

Here is an overview of how Alzheimer's disease affects the brain, and the stages of damage and deterioration:

1. Early stage: In the early stages of Alzheimer's disease, there is a build-up of abnormal proteins, including beta-amyloid plaques and tau tangles, in specific areas of the brain, particularly the hippocampus and entorhinal cortex. This build-up can interfere with communication between brain cells, leading to mild cognitive impairment and memory problems.

2. Mild to moderate stage: As the disease progresses, the abnormal protein build-up spreads throughout the brain, causing more widespread damage and cognitive decline. In this stage, patient may experience more severe memory loss, difficulty with language and communication, confusion, and changes in mood and